共 108 条
- [1] Duncan GW(2014)Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms Mov Disord 29 195-202
- [2] Khoo TK(2018)Parkinson disease with and without dementia: a prevalence study and future projections Mov Disord 33 537-543
- [3] Yarnall AJ(2018)Associations between tau, beta-amyloid, and cognition in Parkinson disease JAMA Neurol 75 227-235
- [4] Savica R(2017)Cognitive decline in Parkinson disease Nat Rev Neurol 13 217-231
- [5] Grossardt BR(2018)Early predictors of mortality in parkinsonism and Parkinson disease: a population-based study Neurology 91 e2045-e2056
- [6] Rocca WA(2018)Strengths and challenges in conducting clinical trials in Parkinson’s disease mild cognitive impairment Mov Disord 33 520-527
- [7] Bower JH(2019)Integrative analysis of blood metabolomics and PET brain neuroimaging data for Parkinson’s disease Neurobiol Dis 124 555-562
- [8] Winer JR(2018)Biomarkers for cognitive dysfunction in Parkinson’s disease Parkinsonism Relat Disord 46 S19-S23
- [9] Maass A(2018)Can neuroimaging predict dementia in Parkinson’s disease? Brain 141 2545-2560
- [10] Pressman P(2012)Cognitive impairment in patients with Parkinson’s disease: diagnosis, biomarkers, and treatment Lancet Neurol 11 697-707